Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	137.29	135.55	66.33	77.62	76.19	31.27
Short-Term Investments	243.05	232.67	365.34	145.92	364.51	244.69
Cash & Short-Term Investments	380.34	368.22	431.67	223.54	440.7	275.96
Cash Growth	7.07%	-14.70%	93.11%	-49.28%	59.69%	33.47%
Accounts Receivable	59.72	41.12	31.06	27.63	26.2	19.93
Other Receivables	2.9	15.7	15.8	1.4	1.3	1
Receivables	62.62	56.82	46.86	29.03	27.5	20.93
Inventory	8.05	7.73	6.1	4.99	4.91	5.42
Prepaid Expenses	15.98	25.86	14.62	8.92	5.4	5.04
Total Current Assets	466.98	458.64	499.25	266.46	478.5	307.36
Property, Plant & Equipment	8.43	0.32	1.78	1.52	4.18	4.5
Long-Term Investments	167.31	57.18	4.95	112.28	36.2	39.35
Long-Term Deferred Tax Assets	126.8	90.61	61.47	27.46	31.6	45.68
Other Long-Term Assets	14.74	14.79	15.99	16.05	21.25	15.43
Total Assets	784.26	621.52	583.43	423.76	571.73	412.31
Accounts Payable	18.58	17.4	11.98	6.91	10.55	7.54
Accrued Expenses	99.9	70.49	44.52	39.3	34.69	28.96
Current Portion of Leases	0.43	0.15	1.14	0.53	2.05	1.56
Current Income Taxes Payable	-	1.81	0.09	0.51	-	-
Other Current Liabilities	7.3	14.65	14.76	0.3	0.2	0.78
Total Current Liabilities	126.22	104.51	72.49	47.54	47.49	38.84
Long-Term Leases	6.36	-	-	-	0.5	1.9
Other Long-Term Liabilities	12.85	10.31	9.1	0.41	0.4	0.39
Total Liabilities	145.42	114.81	81.59	47.95	48.39	41.13
Common Stock	0.14	0.13	0.13	0.13	0.12	0.12
Additional Paid-In Capital	806.32	738.52	662.34	591.35	516.14	457.06
Retained Earnings	512.99	402.53	296.39	194.97	82.46	-23.56
Treasury Stock	-682.18	-635.08	-456.15	-410.41	-75.8	-62.7
Comprehensive Income & Other	1.57	0.61	-0.87	-0.23	0.42	0.26
Shareholders' Equity	638.84	506.71	501.84	375.81	523.34	371.18
Total Liabilities & Equity	784.26	621.52	583.43	423.76	571.73	412.31
Total Debt	6.79	0.15	1.14	0.53	2.55	3.46
Net Cash (Debt)	540.86	425.25	435.48	335.29	474.34	311.85
Net Cash Growth	30.45%	-2.35%	29.88%	-29.32%	52.10%	50.83%
Net Cash Per Share	4.86	3.81	3.76	2.66	3.82	2.54
Filing Date Shares Outstanding	104.78	103.52	107.9	105.96	117.31	114.59
Total Common Shares Outstanding	104.7	103.41	107.84	105.94	116.74	114.55
Working Capital	340.76	354.13	426.76	218.92	431.01	268.52
Book Value Per Share	6.10	4.90	4.65	3.55	4.48	3.24
Tangible Book Value	638.84	506.71	501.84	375.81	523.34	371.18
Tangible Book Value Per Share	6.10	4.90	4.65	3.55	4.48	3.24
Machinery	-	-	-	1.16	0.81	0.3
Leasehold Improvements	-	-	-	1.26	1.23	0.53

Source: S&P Capital IQ. Standard template. Financial Sources.